Response to: Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Neuroimmunology
Published
2025-11-11
DOI
https://doi.org/10.1111/cen3.70038
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Response to: Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis

Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai
Clinical and Experimental Neuroimmunology
Myasthenia Gravis and Thymoma
article

Response to: Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis

Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai
article en

Abstract

No abstract available for this paper.
Clinical and Experimental NeuroimmunologyVol. 17(1)
Chiba University (JP), Alexion Pharmaceuticals (United States) (US), AstraZeneca (United States) (US), International University of Health and Welfare (JP)
AstraZeneca, Alexion Pharmaceuticals
Openalex Percentile: Top 53%
Myasthenia Gravis and Thymoma
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.